The specific assay that is being referred to is called DRUGMATRIX, which essentially involves the inhibition of the phosphodiesterase PDE5 enzyme. In order to carry out this assay, a specific substrate is used, namely [3H]cGMP and cGMP. It is worth noting that this assay is assigned to a direct single protein target. Furthermore, the assay is conducted using platelet cells that are taken from the Homo sapiens organism. This is an in vitro test, the type of which is described as a binding assay. When the assay is conducted, does the molecule possess the ability to bring about the desired outcomes and generate the expected results?